During the past decade, Wake Forest University at Lexington conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest University at Lexington" #1 collaborator was "Canadian Cancer Trials Group" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Wake Forest University at Lexington" are "Anal Basaloid Carcinoma" (1 trials), "Anal Canal Cloacogenic Carcinoma" (1 trials), "Anal Margin Squamous Cell Carcinoma" (1 trials), "Breast Carcinoma" (1 trials) and "Invasive Breast Carcinoma" (1 trials). Many other conditions were trialed in "Wake Forest University at Lexington" in a lesser frequency.

Most popular intervention types in "Wake Forest University at Lexington" are "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Biopsy" (1 trials), "Biopsy of Breast" (1 trials), "Biospecimen Collection" (1 trials) and "Colonoscopy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Forest University at Lexington" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wake Forest University at Lexington". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Wake Forest University at Lexington, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wake Forest University at Lexington, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".